This study utilized the Kaiser Permanente Northern California (KPNC) health care system to evaluate the actual impact of the COVID-19 pandemic on colorectal cancer (CRC).

DEGEA Live – Aufzeichnung vom 20.05.2020 – Thema: COVID-19 – Umsetzung in der Endoskopieabteilung

Klaus Mergener, MD, PhD, FASGE, reviewing Ferretti L, et al. Science 2020 Mar 31. Because effective treatments for COVID-19 are not yet available, we rely

Klaus Mergener, MD, PhD, FASGE, reviewing joint gastroenterology society message on COVID-19 use of personal protective equipment. Gastrointest Endosc 2020 April 2. The GI societies

Klaus Mergener, MD, PhD, FASGE, reviewing Shen C, et al. JAMA 2020 March 27. In this very small case series of 5 critically ill patients

Douglas K. Rex, MD, FASGE, reviewing Xiao F, et al. Gastroenterology 2020 Mar 3. In a Chinese study of 73 patients with proven coronavirus infection,

Douglas K. Rex, MD, FASGE, reviewing Mehta P, et al. Lancet 2020 Mar 16. In a letter to the Lancet, authors argued that secondary hemophagocytic lymphohistiocytosis

These results from China indicate that GI symptoms are common as the chief complaint in COVID-19, though most patients had simultaneous respiratory symptoms. GI symptoms